{{header
 | author     = Mac Thornberry
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2014
 | month      = 06
 | day        = 25
 | notes      = ''{{USBill|113|H.R.|4975}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 2
 | title      = Synthetic Abuse and Labeling of Toxic Substances Act of 2014 ( H.R. 4975; 113th Congress)
 | bill       = 4975
 | billtype   = hr
 | purpose    = To amend the Controlled Substances Act relating to controlled substance analogues.
 | wikipedia  =
}}
      
{{Center|113th CONGRESS}}

 
{{Center|2d Session}}

 
{{Center|H. R. 4975}}

 
{{Center|IN THE HOUSE OF REPRESENTATIVES}}

  
{{Center|June 25, 2014}}

 
{{Center| 
[[w:Mac Thornberry|Mr. Thornberry]](for himself and
[[w:Lamar S. Smith|Mr. Smith of Texas]]) introduced the following bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce]], and in addition to the Committee on the [[w:United States House Committee on the Judiciary|Judiciary]], for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned}}

  
{{Center|A BILL}}

 To amend the Controlled Substances Act relating to controlled substance analogues.   

=Section 1. Short title=

This Act may be cited as the“   Synthetic Abuse and Labeling of Toxic Substances Act of 2014   ”or the“  SALTS Act  ”. 

=Sec. 2. Controlled substance analogues=

   Section 203 of the Controlled Substances Act ( [http://www.law.cornell.edu/uscode/text/21/813 21 U.S.C. 813] )is amended—
:(1) by striking“A controlled”and inserting“(a)In general.—A controlled”; and
:(2) by adding at the end the following:

<blockquote> 

===(b) Determination– ===

In determining whether a controlled substance analogue was intended for human consumption under subsection (a) , the following factors may be considered, along with any other relevant factors:
:(1) The marketing, advertising, and labeling of the substance.
:(2) The known efficacy or usefulness of the substance for the marketed, advertised or labeled purpose.
:(3) The difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold.
:(4) The diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance.
:(5) Whether the defendant knew or should have known the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means. 

===(c) Limitation– ===

For purposes of this section, evidence that a substance was not marketed, advertised, or labeled for human consumption, by itself, shall not be sufficient to establish that the substance was not intended for human consumption. . 
</blockquote>
  
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
